期刊文献+

18F-FDG PET/CT半定量参数在肾上腺病灶鉴别诊断中的价值 被引量:5

The Value of Semi-quantitative Parameters of 18F-FDG PET/CT in the Differential Diagnosis of Adrenal Lesions
原文传递
导出
摘要 [目的]探讨18F-FDG PET/CT半定量参数在鉴别肾上腺病灶中的价值。[方法]对90例疑有肾上腺疾病患者的18F-FDG PET/CT检查结果进行分析。利用半定量分析法,测量所有病灶的T/L SUVmax、SUVmax、肿瘤直径和平均CT值,与最终病理结果比较。[结果]共检出110个病灶,其中恶性肾上腺病灶51例、良性肾上腺病灶39例。恶性肾上腺病灶的平均T/L SUVmax(2.9±1.6)、SUVmax(8.3±5.1)、肿瘤直径(3.1cm±1.6cm)和平均CT值(31.9±7.0Hu)较良性病灶的平均T/L SUVmax(0.9±0.5)、SUVmax(2.7±1.4)、肿瘤直径(2.1cm±1.7cm)和平均CT值(12.1±17.5Hu)显著升高(P均<0.001)。假阳性3例、假阴性2例。ROC曲线分析显示,T/L SUVmax>1.15、SUVmax>3.86、CT值>23.5Hu和肿瘤直径>2.35cm可作为鉴别良恶性肾上腺病灶的最佳截断值。此最佳截断值的ROC曲线下的面积分别为0.95、0.95、0.84和0.76。多变量Logistic回归分析表明T/L SUVmax、SUVmax可作为恶性肾上腺病灶的独立诊断因素(P<0.001)。[结论]当T/L SUVmax>1.15、SUVmax>3.86时,18F-FDG PET/CT在鉴别肾上腺病灶性质中具有较高价值。T/L SUVmax、SUVmax均可作为预测恶性病灶的独立因素,且T/L SUVmax更为客观。 [Objective]To evaluate the value of semi-quantitative parameters of 18F-FDG PET/CT for the differentiation of malignant from benign adrenal lesions.[Methods]Included 90 patients(58 men and 32 women,age 60.1±11.6 year)who had undergone 18F-FDG PET/CT for evaluation of110 adrenal lesions.For semi-quantitative analysis,adrenal to liver(T/L)SUVmaxratio,the maximum standardized uptake value(SUVmax),tumor diameter and mean CT attenuation value were measured in all lesions and compared with the pathological findings.[Results]A total of 110 lesions were detected,including 51 malignant and 39 benign.Malignant adrenal masses had a significantly higher T/L SUVmaxratio(2.9±1.6 vs.0.9±0.5),a higher mean SUVmax(8.3±5.1 vs.2.7±1.4),a greater tumor diameter(3.1±1.6 cm vs.2.1±1.7 cm)and a higher mean CT attenuation value(31.9±7.0 Hu vs.12.1±17.5 Hu)than benign lesions(P<0.001).There were three false positives and two false negatives.Based on ROC curve analysis,a T/L SUVmaxratio>1.15,an adrenal SUVmax>3.86,an attenuation value>23.5 Hu and a tumor diameter>2.35 cm were chosen as the optimal cut-off values for differentiating malignant from benign adrenal masses.The areas under the ROC curves for the selected cut-off values were 0.95,0.95,0.84 and 0.76,respectively.A multivariate logistic regression model revealed that the T/L SUVmaxand SUVmaxwere an independent prognostic factor for malignancy(P<0.001);a CT attenuation value of>23.5 Hu and a tumor diameter>2.35 cm had no additional individual importance in the diagnosis of malignancy.[Conclusion]Using a T/L SUVmax ratio>1.15 and an adrenal SUVmax>3.86 in 18F-FDG PET/CT led to high diagnostic sensitivity,accuracy and positive predictive value for characterizing adrenal lesions.T/L SUVmaxand SUVmaxcould be used as independent predictors of malignancy,however,the T/L SUVmaxis more objective.
作者 王运 李林法 庞伟强 易贺庆 龙斌 叶雪梅 WANG Yun;LI Lin-fa;PANG Wei-qiang;YI He-qing;LONG Bin;YE Xue-mei(Zhejiang Cancer Hospital,Hangzhou 310022,China)
机构地区 浙江省肿瘤医院
出处 《肿瘤学杂志》 CAS 2019年第6期547-551,共5页 Journal of Chinese Oncology
基金 国家卫生计生委科学研究基金-浙江省医药卫生重大科技计划(WKJ-ZJ-1814)
关键词 肾上腺病灶 标准化摄取值 18F-FDG 正电子发射型体层摄影术 ,adrenal lesion SUV 18F-FDG positron-emission tomography
  • 相关文献

参考文献3

二级参考文献41

  • 1刘彤华,陈原稼,武莎菲,高洁,蒋卫君,卢朝辉,关键,魏拴增,罗玉凤,曹金玲,万建伟.良性和恶性嗜铬细胞瘤的区别[J].中华病理学杂志,2004,33(3):198-202. 被引量:29
  • 2赵培勇,刘炳波.母女同患嗜铬细胞瘤误诊为原发性高血压[J].临床心血管病杂志,2005,21(2):96-96. 被引量:2
  • 3闫朝丽,曾正陪,童安莉,卢琳,李明,周亚茹,张晶.嗜铬细胞瘤良、恶性鉴别的临床分析[J].中华医学杂志,2005,85(43):3086-3089. 被引量:10
  • 4钱立新,邵鹏飞,吴宏飞,徐正铨,张炜,张伟明,华立新.肿瘤标记物在恶性嗜铬细胞瘤组织中的表达及意义[J].中华实验外科杂志,2005,22(12):1549-1551. 被引量:5
  • 5陈黎波,李方,景红丽,周前.^(99)Tc^m-HTOC和^(131)Ⅰ-MIBG显像诊断嗜铬细胞瘤的比较[J].中华核医学杂志,2006,26(1):26-28. 被引量:14
  • 6Kikuchi F, Imachi H, Murao K, et al. Positron emission tomography with ^18F-fluorodeoxyglucose is a useful tool for the diagnosis of pheochromocytomas without distant metastasis, where malignancy is suspected on the basis of histopathologic analysis. Am J Med Sci, 2010, 340: 160-163.
  • 7Harari A, Inabnet WB 3rd. Malignant pheochromocytoma: a review. Am J Surg, 2011, 201 : 700-708.
  • 8Ozcan Kara P, Kara T, Kara Gedik G, et al. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions. Nucl Med Commun, 2011,32: 106-112.
  • 9Mackenzie IS, Gumell M, Balan KK, et al. The use of 18-fluorodihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma. Eur J Endocrinol, 2007, 157 : 533-537.
  • 10Eisenhofer G. Free or total metanephrines for diagnosis of pheochro- mocytoma: what is the difference? Clin Chem, 2001,47: 988-989.

共引文献23

同被引文献43

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部